Corneal melting after collagen cross-linking for keratoconus: a case report

Georgios Labiris, Eleni Kaloghianni, Stavrenia Koukoula, Athanassios Zissimopoulos, Vassilios P Kozobolis, Georgios Labiris, Eleni Kaloghianni, Stavrenia Koukoula, Athanassios Zissimopoulos, Vassilios P Kozobolis

Abstract

Introduction: Corneal collagen cross-linking is a rather new technique that uses riboflavin and ultraviolet A light for collagen fiber stabilization in keratoconus corneas. Other than reversible side effects, the preliminary results of corneal collagen cross-linking studies suggest that it is a rather safe technique. In this report, we demonstrate a case of corneal melting after corneal collagen cross-linking for keratoconus corneas associated with an acute inflammatory response.

Case presentation: A 23-year-old Caucasian man with keratoconus cornea stage 1 to 2 underwent uneventful corneal collagen cross-linking treatment according to the Dresden protocol. The next day the patient had intense photophobia, watering and redness of the eye, and his visual acuity was limited to counting fingers. Slit lamp biomicroscopy revealed severe corneal haze accompanied by non-specific endothelial precipitates following an acute inflammatory response. Mild inflammation could be detected in the anterior chamber. Moreover, the re-epithelialization process could barely be detected. His corneal state gradually deteriorated, resulting in descemetocele and finally perforation.

Conclusion: In this report, we present a case of a patient with corneal melting after standard corneal collagen cross-linking treatment for keratoconus corneas following an acute inflammatory response. Despite modifying postoperative treatment, elaboration of all apparent associated causes by the treating physicians and undergoing extensive laboratory testing, the patient developed descemetocele, which led to perforation. Our report suggests that further research is necessary regarding the safety of corneal collagen cross-linking in keratoconus corneas.

Figures

Figure 1
Figure 1
Preoperative Pentacam Oculyzer image of the patient's left eye.
Figure 2
Figure 2
Slit lamp biomicroscopic image showing severe corneal haze and endothelial precipitates due to the acute inflammatory response.

References

    1. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. 1986;101:267–277.
    1. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297–319. doi: 10.1016/S0039-6257(97)00119-7.
    1. Tuft SJ, Moodaley LC, Gregory WM, Davison CR, Buckley RJ. Prognostic factors for the progression of keratoconus. Ophthalmology. 1994;101:439–447.
    1. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine cornea after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003;29:1780–1785. doi: 10.1016/S0886-3350(03)00407-3.
    1. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35–40. doi: 10.1080/02713680490513182.
    1. Kymionis GD, Portaliou DM, Bouzoukis DI, Suh LH, Pallikaris AI, Markomanolakis M, Yoo SH. Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg. 2007;33:1982–1984. doi: 10.1016/j.jcrs.2007.06.036.
    1. Zamora KV, Males JJ. Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report. Cornea. 2009;28:474–476. doi: 10.1097/ICO.0b013e31818d381a.
    1. Kozobolis V, Labiris G, Gkika M, Sideroudi H, Kaloghianni E, Papadopoulou D, Toufexis G. UV-A collagen cross-linking treatment of bullous keratopathy combined with corneal ulcer. Cornea. 2010;29:235–238. doi: 10.1097/ICO.0b013e3181a81802.
    1. Morén H, Malmsjö, Mortensen J, Ohrström A. Riboflavin and ultraviolet A collagen crosslinking of the cornea for the treatment of keratitis. Cornea. 2010;29:102–104.
    1. Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;4:385–389. doi: 10.1097/ICO.0b013e3180334f78.
    1. Gokhale NS, Vemuganti GK. Diclofenac-induced acute corneal melt after collagen crosslinking for keratoconus. Cornea. 2010;29:117–119. doi: 10.1097/ICO.0b013e3181a06c31.
    1. Örnek K, Yalçindağ FN, Özdemir Ö. Corneal melting associated with a fixed-dose combination of diclofenac 0.1% plus tobramycin 0.3% following cataract surgery. J Cataract Refract Surg. 2008;34:1417.
    1. Faschinger C, Kleinert R, Wedrich A. [Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome] [in German] Ophthalmologe. 2010;107:951–955. doi: 10.1007/s00347-009-2127-6.
    1. Angunawela RI, Arnalich-Montiel F, Allan BD. Peripheral sterile corneal infiltrates and melting after collagen crosslinking for keratoconus. J Cataract Refract Surg. 2009;35:606–607. doi: 10.1016/j.jcrs.2008.11.050.
    1. Raiskup F, Hoyer A, Spoerl E. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg. 2009;25:S824–S828. doi: 10.3928/1081597X-20090813-12.
    1. Ou LS, Kuo ML, Huang JL. Anaphylaxis to riboflavin (vitamin B2) Ann Allergy Asthma Immunol. 2001;87:430–433. doi: 10.1016/S1081-1206(10)62927-4.
    1. Mazzotta C, Balestrazzi A, Traversi C, Baiocchi S, Caporossi T, Tommasi C, Caporossi A. Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructular analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans. Cornea. 2007;26:390–397. doi: 10.1097/ICO.0b013e318030df5a.
    1. Kymionis GD, Diakonis VF, Kalyvianaki M, Portaliou D, Siganos C, Kozobolis VP, Pallikaris AI. One-year follow-up of corneal confocal microscopy after corneal cross-linking in patients with post laser in situ keratosmileusis ectasia and keratoconus. Am J Ophthalmol. 2009;147:774–778. doi: 10.1016/j.ajo.2008.11.017. e1.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner